Log in to save to my catalogue

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Repo...

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Repo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4359181

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

About this item

Full title

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

Publisher

Cham: Springer International Publishing

Journal title

Drugs in R&D, 2015, Vol.15 (1), p.45-62

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally assumed to be free from the risk of causing NMS, however several cases of NMS induced by SGAs (SGA-NMS) have been reported.
Objectives
The aim of this study was to syst...

Alternative Titles

Full title

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4359181

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4359181

Other Identifiers

ISSN

1174-5886

E-ISSN

1179-6901

DOI

10.1007/s40268-014-0078-0

How to access this item